Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 235

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 235
---
 “Selling Stockholders,” from time to time, of up to an aggregate of to 37,625,790 Shares
of our Common Stock, including 6,372,265 shares of Common Stock issuable upon exercise of Investor warrants. We are not selling any shares
of our Common Stock under this Prospectus, and we will not receive any proceeds from the sale of Shares of Common Stock offered hereby
by the Selling Stockholders, although we may receive $7,413,436 from the exercise of the outstanding Investor Warrants, if they are exercised
for cash.

You should rely only on the information contained
in or incorporated by reference into this prospectus. Neither we nor the Selling Stockholders have authorized anyone to provide you with
information different from, or in addition to, that contained in or incorporated by reference into this prospectus. This Resale Prospectus
is an offer to sell only the securities offered hereby but only under circumstances and in jurisdictions where it is lawful to do so.
The information contained in or incorporated by reference into this prospectus is current only as of their respective dates or on the
date or dates that are specified in those documents. Our business, financial condition, results of operations and prospects may have
changed since those dates.

The Selling Stockholders are not offering to
sell or seeking offers to purchase these securities in any jurisdiction where the offer or sale is not permitted. Neither we nor the
Selling Stockholders have done anything that would permit this Resale Offering or possession or distribution of this prospectus in any
jurisdiction where action for that purpose is required, other than in the United States. Persons outside the jurisdiction of the United
States who come into possession of this prospectus are required to inform themselves about and to observe any restrictions relating to
this Resale Offering and the distribution of this prospectus applicable to that jurisdiction.

If required, each time each Selling Stockholder
offers shares of Common Stock, we will provide you with, in addition to this prospectus, a prospectus supplement that will contain specific
information about the terms of that offering. We may also authorize aby of the Selling Stockholders to use one or more free writing prospectuses
to be provided to you that may contain material information relating to this Resale Offering. We may also use a prospectus supplement
and any related free writing prospectus to add, update or change any of the information contained in this prospectus or in documents
we have incorporated by reference. This prospectus, together with any applicable